FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

22112211000001104: Vyndaqel 20mg capsules (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Apr 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
73154401000001115 Vyndaqel 20mg capsules (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73154501000001116 Vyndaqel 20mg capsules (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vyndaqel 20mg capsules (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) Has specific active ingredient Tafamidis meglumine true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) Is a Tafamidis meglumine 20mg capsules true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) Has specific active ingredient Tafamidis false Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) Is a Vyndaqel true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) Has specific active ingredient Tafamidis false Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) Has active ingredient Tafamidis true Inferred relationship Existential restriction modifier
Vyndaqel 20mg capsules (Pfizer Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vyndaqel 20mg capsules (Pfizer Ltd) 30 capsule 2 x 15 capsules Has AMP True Vyndaqel 20mg capsules (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start